ADAM12 abrogation alters immune cell infiltration and improves response to checkpoint blockade therapy in the T11 murine model of triple-negative breast cancer.

"the data were retrieved from geo: gse3165 gse8516 gse9343 gse14457 gse15263 gse17916 gse27101 and gse42640; the list and classification of individual samples are based on ref 37 and are included in supplementary table s4.; data availability statement the data that support the findings of this study are openly available in gene expression omnibus at https://www ncbi nlm nih gov/geo/ (gse3165 gse8516 gse9343 gse14457 gse15263 gse17916 gse27101 gse42640 gse104765 and gse124821) human cell atlas immune system at http://immunecellatlas net/ and cbioportal at https://www cbioportal org supplementary material supplemental data for this article can be accessed online at https://doi org/10 1080/2162402x 2022 2158006 data availability statement the data that support the findings of this study are openly available in gene expression omnibus at https://www ncbi nlm nih gov/geo/ (gse3165"

"Disclosure statement The authors declare no conflicts of interest."